Edward Emmett of the School of Medicine comments on the obesity rate in Chester children in comparison to other children.
PHILADELPHIA – Overexpression or hyperactivation of ErbB cell-surface receptors drives the growth of many breast cancers. Drugs, like Herceptin, that block the receptors’ signals halt tumor progression in some patients. However, not all patients’ tumors respond, with some becoming resistant over time. Different drugs that interfere with other steps in the signaling pathway may improve the response of patients, yet little is known about these molecules.
Les Shaw and John Trojanowski of the School of Medicine are cited for their contributions to an early diagnosis for Alzheimer’s.
Mark Pauly of the Wharton School shares his perspective on strategies to tackle health-care policies.
Arthur Caplan of the School of Medicine asks, “Is it ethical to create new life forms? What are the religious concerns?”
Marjorie Jeffcoat of the School of Dental Medicine comments on a federal panel’s precautionary steps for dental-filling safety.